{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:34:26Z","timestamp":1772120066607,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01318-4","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:34:24Z","timestamp":1763548464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and characterization of a novel cell line ICH-BCPALL-3 from B cell precursor acute lymphoblastic leukemia with TCF3::HLF"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0135-5431","authenticated-orcid":false,"given":"Keisuke","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Panagopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Ikenobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Sagisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minori","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Kiyokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"1318_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","volume":"2","author":"S Jeha","year":"2021","unstructured":"Jeha S, Choi J, Roberts KG, Pei D, Coustan-Smith E, Inaba H, et al. Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. Blood Cancer Discov. 2021;2:326\u201337. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0229.","journal-title":"Blood Cancer Discov"},{"key":"1318_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41591-022-02112-7","volume":"29","author":"SHR Lee","year":"2023","unstructured":"Lee SHR, Yang W, Gocho Y, John A, Rowland L, Smart B, et al. Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response. Nat Med. 2023;29:170\u20139. https:\/\/doi.org\/10.1038\/s41591-022-02112-7.","journal-title":"Nat Med"},{"key":"1318_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.1386162","volume":"257","author":"T Inaba","year":"1992","unstructured":"Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science. 1992;257:531\u20134. https:\/\/doi.org\/10.1126\/science.1386162.","journal-title":"Science"},{"key":"1318_CR4","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1101\/gad.6.9.1608","volume":"6","author":"SP Hunger","year":"1992","unstructured":"Hunger SP, Ohyashiki K, Toyama K, Cleary ML. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev. 1992;6:1608\u201320. https:\/\/doi.org\/10.1101\/gad.6.9.1608.","journal-title":"Genes Dev"},{"key":"1318_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/sj.leu.2404496","volume":"21","author":"T Inukai","year":"2007","unstructured":"Inukai T, Hirose K, Inaba T, Kurosawa H, Hama A, Inada H, et al. Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19. Leukemia. 2007;21:288\u201396. https:\/\/doi.org\/10.1038\/sj.leu.2404496.","journal-title":"Leukemia"},{"key":"1318_CR6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.3362","volume":"47","author":"U Fischer","year":"2015","unstructured":"Fischer U, Forster M, Rinaldi A, Risch T, Sungalee S, Warnatz HJ, et al. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. Nat Genet. 2015;47:1020\u20139. https:\/\/doi.org\/10.1038\/ng.3362.","journal-title":"Nat Genet"},{"key":"1318_CR7","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1002\/cam4.2356","volume":"8","author":"A Watanabe","year":"2019","unstructured":"Watanabe A, Inukai T, Kagami K, Abe M, Takagi M, Fukushima T, et al. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy. Cancer Med. 2019;8:5274\u201388. https:\/\/doi.org\/10.1002\/cam4.2356.","journal-title":"Cancer Med"},{"key":"1318_CR8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/jjco\/hyy071","volume":"48","author":"K Koh","year":"2018","unstructured":"Koh K, Kato M, Saito AM, Kada A, Kawasaki H, Okamoto Y, et al. Phase II\/III study in children and adolescents with newly diagnosed B cell precursor acute lymphoblastic leukemia: protocol for a nationwide multicenter trial in Japan. Jpn J Clin Oncol. 2018;48:684\u201391. https:\/\/doi.org\/10.1093\/jjco\/hyy071.","journal-title":"Jpn J Clin Oncol"},{"key":"1318_CR9","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1038\/bcj.2014.52","volume":"4","author":"AL Samuels","year":"2014","unstructured":"Samuels AL, Beesley AH, Yadav BD, Papa RA, Sutton R, Anderson D, et al. A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia. Blood Cancer J. 2014;4:e232. https:\/\/doi.org\/10.1038\/bcj.2014.52.","journal-title":"Blood Cancer J"},{"key":"1318_CR10","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.1038\/s41598-019-44491-x","volume":"9","author":"H Quentmeier","year":"2019","unstructured":"Quentmeier H, Pommerenke C, Dirks WG, Eberth S, Koeppel M, MacLeod RAF, et al. The LL-100 panel: 100 cell lines for blood cancer studies. Sci Rep. 2019;9:8218. https:\/\/doi.org\/10.1038\/s41598-019-44491-x.","journal-title":"Sci Rep"},{"key":"1318_CR11","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/S0140-6736(10)62002-8","volume":"376","author":"C Parker","year":"2010","unstructured":"Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV, et al. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet. 2010;376:2009\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(10)62002-8.","journal-title":"Lancet"},{"key":"1318_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pbc.21753","volume":"52","author":"TC Griffin","year":"2009","unstructured":"Griffin TC, Weitzman S, Weinstein H, Chang M, Cairo M, Hutchison R, et al. A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent\/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2009;52:177\u201381. https:\/\/doi.org\/10.1002\/pbc.21753.","journal-title":"Pediatr Blood Cancer"},{"key":"1318_CR13","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.3324\/haematol.2018.210104","volume":"104","author":"B Mouttet","year":"2019","unstructured":"Mouttet B, Vinti L, Ancliff P, Bodmer N, Brethon B, Cario G, et al. Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation. Haematologica. 2019;104:e244\u20137. https:\/\/doi.org\/10.3324\/haematol.2018.210104.","journal-title":"Haematologica"},{"key":"1318_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.leukres.2013.10.008","volume":"38","author":"N Kiyokawa","year":"2014","unstructured":"Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, et al. Significance of CD66c expression in childhood acute lymphoblastic leukemia. Leuk Res. 2014;38:42\u20138. https:\/\/doi.org\/10.1016\/j.leukres.2013.10.008.","journal-title":"Leuk Res"},{"key":"1318_CR15","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ van Dongen","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Br\u00fcggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17:2257\u2013317. https:\/\/doi.org\/10.1038\/sj.leu.2403202.","journal-title":"Leukemia"},{"key":"1318_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","volume":"20","author":"BJ Haas","year":"2019","unstructured":"Haas BJ, Dobin A, Li B, Stransky N, Pochet N, Regev A. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 2019;20:213. https:\/\/doi.org\/10.1186\/s13059-019-1842-9.","journal-title":"Genome Biol"},{"key":"1318_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40164-019-0136-y","volume":"8","author":"I Panagopoulos","year":"2019","unstructured":"Panagopoulos I, Brunetti M, Stoltenberg M, Strandab\u00f8 RAU, Staurseth J, Andersen K, et al. Novel GTF2I-PDGFRB and IKZF1-TYW1 fusions in pediatric leukemia with normal karyotype. Exp Hematol Oncol. 2019;8:12. https:\/\/doi.org\/10.1186\/s40164-019-0136-y.","journal-title":"Exp Hematol Oncol"},{"key":"1318_CR18","first-page":"1\u201326","volume-title":"Human cytogenetics: Malignancy and acquired abnormalities","author":"B Czepulkowski","year":"2001","unstructured":"Czepulkowski B. Basic techniques for the preparation and analysis of chromosomes from bone marrow and leukaemic blood. In: Rooney DE, editor. Human cytogenetics: Malignancy and acquired abnormalities. New York: Oxford University Press; 2001. p. 1-26-57\u201386."},{"key":"1318_CR19","doi-asserted-by":"publisher","DOI":"10.1159\/isbn.978-3-318-06867-2","volume-title":"ISCN 2020: an international system for human cytogenomic nomenclature","author":"J McGowan-Jordan","year":"2020","unstructured":"McGowan-Jordan J, Hastings RJ, Moore S. ISCN 2020: an international system for human cytogenomic nomenclature. Bazel: Karger AG; 2020."},{"key":"1318_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12013-011-9285-2","volume":"62","author":"G Imataka","year":"2012","unstructured":"Imataka G, Arisaka O. Chromosome analysis using spectral karyotyping (SKY). Cell Biochem Biophys. 2012;62:13\u20137. https:\/\/doi.org\/10.1007\/s12013-011-9285-2.","journal-title":"Cell Biochem Biophys"},{"key":"1318_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cancergen.2012.10.004","volume":"205","author":"I Panagopoulos","year":"2012","unstructured":"Panagopoulos I, Micci F, Thorsen J, Haugom L, Tierens A, Ulvmoen A, et al. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13). Cancer Genet. 2012;205:669\u201372. https:\/\/doi.org\/10.1016\/j.cancergen.2012.10.004.","journal-title":"Cancer Genet"},{"key":"1318_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21873\/cgp.20247","volume":"18","author":"I Panagopoulos","year":"2021","unstructured":"Panagopoulos I, Andersen K, Eilert-Olsen M, Rognlien AG, Munthe-Kaas MC, Micci F, et al. Rare KMT2A-ELL and novel ZNF56-KMT2A fusion genes in pediatric T-cell acute lymphoblastic leukemia. Cancer Genomics Proteomics. 2021;18:121\u201331. https:\/\/doi.org\/10.21873\/cgp.20247.","journal-title":"Cancer Genomics Proteomics"},{"key":"1318_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/011650","author":"D Nicorici","year":"2014","unstructured":"Nicorici D, Satalan H, Edgren H, Kangaspeska S, Murumagi A, Kallioniemi O, et al. Fusioncatcher \u2013 a tool for finding somatic fusion genes in paired-end rna-sequencing data. bioRxiv. 2014. https:\/\/doi.org\/10.1101\/011650.","journal-title":"bioRxiv"},{"key":"1318_CR24","doi-asserted-by":"publisher","first-page":"e11318","DOI":"10.1371\/journal.pone.0011318","volume":"5","author":"H Singhal","year":"2010","unstructured":"Singhal H, Ren YR, Kern SE. Improved DNA electrophoresis in conditions favoring polyborates and lewis acid complexation. PLoS One. 2010;5:e11318. https:\/\/doi.org\/10.1371\/journal.pone.0011318.","journal-title":"PLoS One"},{"key":"1318_CR25","doi-asserted-by":"publisher","first-page":"e70736","DOI":"10.1002\/cam4.70736","volume":"14","author":"M Tamai","year":"2025","unstructured":"Tamai M, Komatsu C, Kagami K, Kasai S, Akahane K, Goi K, et al. Utility of a large series of B-cell precursor acute lymphoblastic leukemia cell lines as a model system. Cancer Med. 2025;14:e70736. https:\/\/doi.org\/10.1002\/cam4.70736.","journal-title":"Cancer Med"},{"key":"1318_CR26","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560.","journal-title":"Bioinformatics"},{"key":"1318_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. https:\/\/doi.org\/10.1186\/1471-2105-12-323.","journal-title":"BMC Bioinformatics"},{"key":"1318_CR28","doi-asserted-by":"publisher","first-page":"lqae151","DOI":"10.1093\/nargab\/lqae151","volume":"6","author":"PL Baldoni","year":"2024","unstructured":"Baldoni PL, Chen L, Smyth GK. Faster and more accurate assessment of differential transcript expression with Gibbs sampling and edgeR v4. NAR Genomics Bioinform. 2024;6:lqae151. https:\/\/doi.org\/10.1093\/nargab\/lqae151.","journal-title":"NAR Genomics Bioinform"},{"key":"1318_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"1318_CR30","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge SX, Son EW, Yao R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinformatics. 2018;19:534. https:\/\/doi.org\/10.1186\/s12859-018-2486-6.","journal-title":"BMC Bioinformatics"},{"key":"1318_CR31","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1162\/neco_a_01434","volume":"33","author":"T Sainburg","year":"2021","unstructured":"Sainburg T, McInnes L, Gentner TQ. Parametric UMAP embeddings for representation and semisupervised learning. Neural Comput. 2021;33:2881\u2013907. https:\/\/doi.org\/10.1162\/neco_a_01434.","journal-title":"Neural Comput"},{"key":"1318_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00280-020-04045-9","volume":"85","author":"H Goto","year":"2020","unstructured":"Goto H, Yoshino Y, Ito M, Nagai J, Kumamoto T, Inukai T, et al. Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2020;85:773\u201383. https:\/\/doi.org\/10.1007\/s00280-020-04045-9.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1318_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/1471-2407-14-709","volume":"14","author":"A Szulkin","year":"2014","unstructured":"Szulkin A, Otv\u00f6s R, Hillerdal CO, Celep A, Yousef-Fadhel E, Skribek H, et al. Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions. BMC Cancer. 2014;14:709. https:\/\/doi.org\/10.1186\/1471-2407-14-709.","journal-title":"BMC Cancer"},{"key":"1318_CR34","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/bjh.17970","volume":"196","author":"T Yokosuka","year":"2022","unstructured":"Yokosuka T, Ito M, Yoshino Y, Hirose A, Nakamura W, Sakurai Y, et al. Using the in vitro drug sensitivity test to identify candidate treatments for transient abnormal myelopoiesis. Br J Haematol. 2022;196:764\u20138. https:\/\/doi.org\/10.1111\/bjh.17970.","journal-title":"Br J Haematol"},{"key":"1318_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fgene.2020.00598","volume":"11","author":"P Wang","year":"2020","unstructured":"Wang P, Deng Y, Yan X, Zhu J, Yin Y, Shu Y, et al. The role of ARID5B in acute lymphoblastic leukemia and beyond. Front Genet. 2020;11:598. https:\/\/doi.org\/10.3389\/fgene.2020.00598.","journal-title":"Front Genet"},{"key":"1318_CR36","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1038\/s41598-019-41078-4","volume":"9","author":"EMP Steeghs","year":"2019","unstructured":"Steeghs EMP, Boer JM, Hoogkamer AQ, Boeree A, de Haas V, de Groot-Kruseman HA, et al. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Sci Rep. 2019;9:4634. https:\/\/doi.org\/10.1038\/s41598-019-41078-4.","journal-title":"Sci Rep"},{"key":"1318_CR37","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3109\/10428194.2015.1088650","volume":"57","author":"R Grausenburger","year":"2016","unstructured":"Grausenburger R, Bastelberger S, Eckert C, Kauer M, Stanulla M, Frech C, et al. Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6\/RUNX1-positive acute lymphoblastic leukemia. Leuk Lymphoma. 2016;57:1163\u201373. https:\/\/doi.org\/10.3109\/10428194.2015.1088650.","journal-title":"Leuk Lymphoma"},{"key":"1318_CR38","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41375-021-01132-5","volume":"35","author":"Z Ge","year":"2021","unstructured":"Ge Z, Song C, Ding Y, Tan BH, Desai D, Sharma A, et al. Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia. Leukemia. 2021;35:1267\u201378. https:\/\/doi.org\/10.1038\/s41375-021-01132-5.","journal-title":"Leukemia"},{"key":"1318_CR39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.leu.2402120","volume":"15","author":"H Takahashi","year":"2001","unstructured":"Takahashi H, Goto H, Eunabiki T, Fujii H, Yamazaki S, Fujioka K, et al. Expression of two types of E2A-HLF fusion proteins in YCUB-2, a novel cell line established from B-lineage leukemia with t(17;19). Leukemia. 2001;15:995\u20137. https:\/\/doi.org\/10.1038\/sj.leu.2402120.","journal-title":"Leukemia"},{"key":"1318_CR40","first-page":"322","volume":"5","author":"K Ohyashiki","year":"1991","unstructured":"Ohyashiki K, Fujieda H, Miyauchi J, Ohyashiki JH, Tauchi T, Saito M, et al. Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3. Leukemia. 1991;5:322\u201331.","journal-title":"Leukemia"},{"key":"1318_CR41","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1128\/mcb.14.5.3403-3413.1994","volume":"14","author":"T Inaba","year":"1994","unstructured":"Inaba T, Shapiro LH, Funabiki T, Sinclair AE, Jones BG, Ashmun RA, et al. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein. Mol Cell Biol. 1994;14:3403\u201313. https:\/\/doi.org\/10.1128\/mcb.14.5.3403-3413.1994.","journal-title":"Mol Cell Biol"},{"key":"1318_CR42","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1182\/blood-2009-09-244673","volume":"116","author":"K Hirose","year":"2010","unstructured":"Hirose K, Inukai T, Kikuchi J, Furukawa Y, Ikawa T, Kawamoto H, et al. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19). Blood. 2010;116:962\u201370. https:\/\/doi.org\/10.1182\/blood-2009-09-244673.","journal-title":"Blood"},{"key":"1318_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/gcc.22998","volume":"61","author":"M Salim","year":"2022","unstructured":"Salim M, Heldt F, Thomay K, Lentes J, Behrens YL, Kaune B, et al. Cryptic TCF3 fusions in childhood leukemia: detection by RNA sequencing. Genes Chromosomes Cancer. 2022;61:22\u20136. https:\/\/doi.org\/10.1002\/gcc.22998.","journal-title":"Genes Chromosomes Cancer"},{"key":"1318_CR44","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2008.10.035","volume":"135","author":"AG Tsai","year":"2008","unstructured":"Tsai AG, Lu H, Raghavan SC, Muschen M, Hsieh CL, Lieber MR. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell. 2008;135:1130\u201342. https:\/\/doi.org\/10.1016\/j.cell.2008.10.035.","journal-title":"Cell"},{"key":"1318_CR45","doi-asserted-by":"publisher","first-page":"109387","DOI":"10.1016\/j.celrep.2021.109387","volume":"36","author":"D Liu","year":"2021","unstructured":"Liu D, Loh YE, Hsieh CL, Lieber MR. Mechanistic basis for chromosomal translocations at the E2A gene and its broader relevance to human B cell malignancies. Cell Rep. 2021;36:109387.","journal-title":"Cell Rep"},{"key":"1318_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1073\/pnas.0711334105","volume":"105","author":"JE Haber","year":"2008","unstructured":"Haber JE. Alternative endings. Proc Natl Acad Sci U S A. 2008;105:405\u20136. https:\/\/doi.org\/10.1073\/pnas.0711334105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1318_CR47","doi-asserted-by":"publisher","first-page":"e27062","DOI":"10.1002\/pbc.27062","volume":"65","author":"AE Place","year":"2018","unstructured":"Place AE, Pikman Y, Stevenson KE, Harris MH, Pauly M, Sulis ML, et al. Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2018;65(7):e27062. https:\/\/doi.org\/10.1002\/pbc.27062.","journal-title":"Pediatr Blood Cancer"},{"key":"1318_CR48","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","volume":"120","author":"SK Tasian","year":"2012","unstructured":"Tasian SK, Doral MY, Borowitz MJ, Wood BL, Chen IM, Harvey RC, et al. Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. Blood. 2012;120:833\u201342. https:\/\/doi.org\/10.1182\/blood-2011-12-389932.","journal-title":"Blood"},{"key":"1318_CR49","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3324\/haematol.2017.185975","volume":"104","author":"EC Matheson","year":"2019","unstructured":"Matheson EC, Thomas H, Case M, Blair H, Jackson RK, Masic D, et al. Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM. Haematologica. 2019;104:1804\u201311. https:\/\/doi.org\/10.3324\/haematol.2017.185975.","journal-title":"Haematologica"},{"key":"1318_CR50","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1182\/blood-2016-09-738070","volume":"129","author":"V Frismantas","year":"2017","unstructured":"Frismantas V, Dobay MP, Rinaldi A, Tchinda J, Dunn SH, Kunz J, et al. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia. Blood. 2017;129:e26\u201337. https:\/\/doi.org\/10.1182\/blood-2016-09-738070.","journal-title":"Blood"},{"key":"1318_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41419-024-06864-7","volume":"15","author":"S Enzenm\u00fcller","year":"2024","unstructured":"Enzenm\u00fcller S, Niedermayer A, Seyfried F, Muench V, Tews D, Rupp U, et al. Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation. Cell Death Dis. 2024;15:475. https:\/\/doi.org\/10.1038\/s41419-024-06864-7.","journal-title":"Cell Death Dis"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01318-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01318-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01318-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:34:25Z","timestamp":1763548465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01318-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01318-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5469901\/v1","asserted-by":"object"}]},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in the current study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental design and procedure were approved by the Institutional Review Board of Ibaraki Children\u2019s Hospital (IRB approval number 1IRB-33) in accordance with Helsinki Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We have obtained the informed consent from the guardian of the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"11"}}